Hour24 News
Sophisticated and simple
-
Overview of EMBARK Topline Results Sarepta Therapeutics announced positive topline results from three years of follow-up in the EMBARK study evaluating ELEVIDYS, the company’s gene…
Sophisticated and simple
Overview of EMBARK Topline Results Sarepta Therapeutics announced positive topline results from three years of follow-up in the EMBARK study evaluating ELEVIDYS, the company’s gene…